RedHill Biopharma Announces U.S. Commercialization Agreement for FDA-Approved GI Product Esomeprazole Strontium Delayed-Release Capsules Aug 18, 2017 Life Science
Harbin Gloria, WuXi Biologics Sign $818 Million Deal for Ex-China Rights to PD-1 Candidate Aug 17, 2017 Life Science
Shenzhen Royal Asset to Pay $33 Million for Fibrosis Candidates from Prometic Aug 14, 2017 Life Science
Fosun and Shanghai Pharmas Competing for $700 Million Stake in US-based Arbor Aug 11, 2017 Life Science
